Skip to content

Unbelievable! WHAM Raises the Roof as They Mark 30 Epic Years of Revolutionizing Medical Research for Women

Expanding Women’s Health Access: WHAM Launches #3Not30 Campaign to Accelerate and Invest in Women’s Health

Women’s Health Access Matters (WHAM) is taking a proactive stance to improve women’s health by launching the #3Not30 campaign in Washington DC. The campaign aims to accelerate and invest in women’s health over the next three years, building on the progress made by the NIH Revitalization Act of 1993.

Commemorating the 30th anniversary of the NIH Revitalization Act, WHAM organized a celebration featuring prominent leaders such as Hon. Barbara Mikulski, Hon. Connie Morella, and Dr. Vivian Pinn. These leaders, alongside current lawmakers, emphasized the importance of greater inclusion of women in research and clinical trials.

Despite the significant strides made by the NIH Revitalization Act, Speaker Nancy Pelosi acknowledged that there is still much work to be done. Women’s health has been historically understudied and underrepresented, resulting in underinvestment in research and negative economic implications. Addressing these issues is crucial, as it affects not only women but also their families and society at large.

To drive change and accelerate investment in women’s health, WHAM has commissioned the RAND Corporation to conduct a series of studies. These studies examine the impact of accelerating sex and gender-based health research on women, their families, and the economy. The studies found that there is a significant disparity in research allocation, with only a small percentage dedicated to projects specifically focused on women’s health.

WHAM’s #3Not30 campaign seeks to raise awareness and drive change by emphasizing the need for investment in gender-based research over the next three years. By investing just $350 million in research on diseases that affect women differently and disproportionately, such as coronary artery disease, autoimmune rheumatoid arthritis, Alzheimer’s, and lung cancer, it is estimated that the returns would be almost $14 billion.

In addition to the campaign, WHAM has hosted virtual and in-person dialogues throughout the year to assess the progress made since the NIH Revitalization Act and develop strategies to ensure women’s health research receives the funding and support it deserves.

As part of the campaign, a roundtable discussion was held in Washington D.C., co-moderated by Dr. Maria Freire and Ash Shehata. This discussion included business leaders, investors, advocates, economists, and academics from various sectors. The goal was to collaborate and create an action plan for the next three years, focusing on accelerating research and investment in women’s health.

WHAM’s CEO, Carolee Lee, emphasized the urgency of investing in women’s health research. Despite women representing a significant portion of the population, workforce, and consumer spending, the investment in women’s health research has not matched these figures. By equitably funding research on diseases that disproportionately affect women, everyone stands to benefit.

To stay informed about future WHAM #3Not30 activities, individuals can sign up for the WHAM newsletter and follow the organization on Instagram, LinkedIn, and Twitter.

Summary:

WHAM has launched the #3Not30 campaign to accelerate and invest in women’s health over the next three years. Commemorating the 30th anniversary of the NIH Revitalization Act, the campaign seeks to raise awareness and drive change in gender-based research funding. By addressing the historical underinvestment in women’s health research, WHAM aims to improve health outcomes for women, families, and society as a whole. The campaign includes roundtable discussions, commissioned studies, and collaboration with various stakeholders to develop an action plan for the future. WHAM emphasizes the economic importance of investing in women’s health research and aims to achieve equitable funding to study diseases that disproportionately affect women.

—————————————————-

Article Link
UK Artful Impressions Premiere Etsy Store
Sponsored Content View
90’s Rock Band Review View
Ted Lasso’s MacBook Guide View
Nature’s Secret to More Energy View
Ancient Recipe for Weight Loss View
MacBook Air i3 vs i5 View
You Need a VPN in 2023 – Liberty Shield View

WHAM LAUNCHES #3NOT30 CAMPAIGN TO CALL TO ACCELERATE AND INVEST IN WOMEN’S HEALTH OVER THE NEXT THREE YEARS

Women’s Health Access Matters (WHAM) announces a commemoration in Washington DC, with the Hon. Barbara Mikulski, Hon. Connie Morella, Dr. Vivian Pinn, and current lawmakers who support greater inclusion of women in research and clinical trials

WASHINGTON, June 15, 2023 /PRNewswire/ — Speaker Emeritus Nancy Pelosi kicked off a 30th birthday celebrationhe Anniversary of the NIH Revitalization Act of 1993 to recognize the contributions of the extraordinary leaders who spearheaded successful legislation thirty years ago establishing the inclusion of women in clinical trials and research. The celebration was organized by WHAM (Women’s Health Access Matters) and featured a private lunch and panel discussion at Washington D.C.

the honorable Barbara MikulskiHonorable Connie Morellaand dr. viviana pinnas well as today’s leaders, Dr. Janine Clayton and current members of Congress, who support accelerating research and investment in women’s health, participated in a panel discussion highlighting the past contributions of these incredible leaders. This was followed by a roundtable discussion with twenty of WHAM’s partners and thought leaders to develop and steer an action plan for the future, implementing change in #3Not30 years.

Speaker Pelosi noted that women’s health has been understudied and underrepresented, and the efforts of Mikulski, Morella, and Pinn put us on the right track, but there is still much work to be done.

“While the Revitalization Act was a step forward for gender-based equity in health research, there hasn’t been enough progress since this momentous event,” said the WHAM founder and CEO. carolee lee. “For decades, women’s health has suffered as a result of underinvestment in research. Women have also been forced to leave the workforce early to manage their own health or care for loved ones. This It’s an economic problem that affects everyone, and we can’t afford to ignore it. We can’t wait another thirty years.”

Tribute videos of Sen. patty murray; Senator amy klobuchar; Rep. Barbara Lee; Senator Lisa Murkowski; Senator dick durbin; Senator tammy duckworth; Rep. judy chu; Rep. katherine clark; and Senator Shelley Moore Capito, who applauded the work of Sen. Barbara Mikulski; Rep. Connie Morella and dr. viviana pinn and emphatically declared their support for WHAM and the acceleration of research and equality.

WHAM commissioned the RAND Corporation to conduct a series of studies examining the impact of accelerating sex and gender-based health research on women, their families, and the economy. He WHAM report found that only 4.5 percent of research on coronary arteries, 7 percent of research on autoimmune rheumatoid arthritis, 12 percent of research on Alzheimer’s, and 15 percent of research on lung cancer are allocated to projects specifically focused on women. adding only $350 million in funding these four disease areas, brain, heart, cancer and autoimmune, which affect women differently and disproportionately, would generate almost $14 billion in economic returns that benefit everyone.

WHAM’s #3Not30 campaign is a year-long effort to raise awareness of women’s health research and drive change with the goal of accelerating investment in gender-based research over the next three years. The campaign is the first in a series of activities WHAM is spearheading in recognition of the 30th anniversary of the 1993 National Institutes of Health (NIH) Revitalization Act, a law that established guidelines that women and Minorities must be included in all clinical trials and research funded by the NIH. WHAM has hosted virtual and in-person dialogues throughout the year to explore what has changed since this landmark legislation, what hasn’t, and how to ensure women’s health research receives the funding and support it deserves.

The Round Table Dialogue in Washington D.C. was co-moderated by Dr. Maria Freire, former President and CEO of FNIH, and Ash Shehata, National Sector Leader: Healthcare and Life Sciences at KPMG. They were joined by business leaders, investors, advocates, economists and academics to discuss how WHAM economic data can be used across sectors to accelerate research and investment in women’s health at #3Not30. The goal is to develop an action plan for the next three years, not

thirty, which will accelerate research and investment in women’s health. The twenty leaders represent different sectors of the ecosystem and contributed their vision of how their company, institution or platform can generate an impactful and sustainable change. The round table featured:

  • Michael AnnichineCEO, Magee-Women Research Institute;
  • tom cassellsPresident and CEO of Rock Health;
  • Dr. Janine Claytondirector of the NIH Office of Research on Women’s Health;
  • Esther DysonExecutive Founder, Wellville;
  • jessica federerManaging Partner, Supernode Ventures;
  • Laurie Fenton AmbroseCo-Founder, President and CEO, GO2 for Lung Cancer;
  • Dr. lori frankSenior Vice President for Research, New York Academy of Medicine;
  • Dr. elizabeth garner, Chief Scientific Officer, Ferring Pharmaceuticals; President, American Association of Medical Women;
  • Dr. julie gerberdingPresident and CEO, FNIH;
  • Stacey HallerPresident and CEO, BrightFocus Foundation;
  • marsha hendersonformer Associate Commissioner for Women’s Health, FDA;
  • Dr. Hadine JoffeExecutive Director, The Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital, Harvard Medical School;
  • sasha kelemenHead of Investment Banking in Women’s and Family Health, SVB Securities
  • sheila mikhailCo-Founder and Advisor, Asklepios BioPharmaceutical, Inc. (AskBio);
  • melissa gong mitchellExecutive Director, Global Coalition on Aging;
  • Dr. Erica Ollmann SapphirePresident, CEO and Professor, La Jolla Institute for Immunology;
  • Dr. Stacey RosenSenior Vice President of Women’s Health, Katz Institute for Women’s Health, Northwell Health;
  • Dr. Ellen Sigalpresident and founder of Friends of Cancer Research;
  • tandon twigClinical Trials Director, Walgreens

“For thirty years, investment in women’s health research has lagged behind, resulting in poor health and economic outcomes for women, families and the nation,” Lee said. “This is the reality despite the fact that women are 52 percent of the population, make up 50 percent of the labor force, control 60 percent of personal wealth, are responsible for 85 percent of the spending of the consumers and make 80 percent of health care decisions. Let’s seize this moment and use it as an opportunity to equitably fund the study of diseases that clearly affect women disproportionately and differently. If we can achieve this as a country, we will all come out winning”.

To stay informed about future WHAM #3Not30 activities, sign up for the WHAM newsletter here. And follow WHAM throughout the year on instagram, LinkedIn, and Twitter to stay up to date on the #3Not30 campaign and the latest in women’s health research.

About WHAM (Women’s Health Access Matters)
Women’s health is an economic problem that we cannot afford to ignore. WHAM works to increase awareness and funding for research and investment in women’s health by accelerating scientific discovery in women’s health across four major disease verticals: autoimmune diseases, brain health, cancer, and heart health. The WHAM Report quantifies the economic opportunity of investing in women’s health, looking at diseases that affect women differently and differentially, including coronary artery disease, rheumatoid arthritis, and Alzheimer’s disease. Learn more at www.thewhamreport.org and www.whamnow.org.

WHAM SOURCE




https://www.prnewswire.com/news-releases/wham-celebrates-the-30th-anniversary-of-the-1993-nih-revitalization-act-to-ensure-women-included-in-research-and-clinical-trials-301852529.html
—————————————————-